OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of bile acids in cholestatic liver injury
Shi‐Ying Cai, James L. Boyer
Annals of Translational Medicine (2021) Vol. 9, Iss. 8, pp. 737-737
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Drug induced liver injury – a 2023 update
Rebecca Allison, Asha Guraka, Isaac Thom Shawa, et al.
Journal of Toxicology and Environmental Health Part B (2023) Vol. 26, Iss. 8, pp. 442-467
Open Access | Times Cited: 44

A Current Understanding of Bile Acids in Chronic Liver Disease
Naba Farooqui, Anshuman Elhence, S. Shalimar
Journal of Clinical and Experimental Hepatology (2021) Vol. 12, Iss. 1, pp. 155-173
Open Access | Times Cited: 58

Total Flavonoids of Rhizoma Drynariae Mitigates Aflatoxin B1-Induced Liver Toxicity in Chickens via Microbiota-Gut-Liver Axis Interaction Mechanisms
Shucheng Huang, Luxi Lin, Shiqiong Wang, et al.
Antioxidants (2023) Vol. 12, Iss. 4, pp. 819-819
Open Access | Times Cited: 25

Hepatic stellate cells in the injured liver: Perspectives beyond hepatic fibrosis
Devaraj Ezhilarasan
Journal of Cellular Physiology (2021) Vol. 237, Iss. 1, pp. 436-449
Closed Access | Times Cited: 50

Wedelolactone alleviates cholestatic liver injury by regulating FXR-bile acid-NF-κB/NRF2 axis to reduce bile acid accumulation and its subsequent inflammation and oxidative stress
Meiqi Wang, Kai-Hui Zhang, Fangle Liu, et al.
Phytomedicine (2023) Vol. 122, pp. 155124-155124
Closed Access | Times Cited: 19

Potential therapeutic action of tauroursodeoxycholic acid against cholestatic liver injury via hepatic Fxr/Nrf2 and CHOP-DR5-caspase-8 pathway
Guochao Song, Fengyi Weng, Bin Zou, et al.
Clinical Science (2023) Vol. 137, Iss. 7, pp. 561-577
Open Access | Times Cited: 14

Seladelpar treatment reduces IL-31 and pruritus in patients with primary biliary cholangitis
Andreas E. Kremer, Marlyn J. Mayo, Gideon M. Hirschfield, et al.
Hepatology (2023) Vol. 80, Iss. 1, pp. 27-37
Open Access | Times Cited: 14

Discovery of Fluorescent Probe ABDS-2 for Farnesoid X Receptor Modulator Characterization and Cell-Based Imaging
Xianjie Qiu, Wenqi Li, Xiaoqin Li, et al.
Analytical Chemistry (2025)
Closed Access

Studying the intracellular bile acid concentration and toxicity in drug-induced cholestasis: Comprehensive LC-MS/MS analysis with human liver slices
Ruby E. H. Karsten, Konstanze Gier, Vincent E. de Meijer, et al.
Toxicology in Vitro (2025), pp. 106011-106011
Closed Access

Ribes diacanthum Pall modulates bile acid homeostasis and oxidative stress in cholestatic mice by activating the SIRT1/FXR and Keap1/Nrf2 signaling pathways
Alamusi Bayoude, Jiaxin Zhang, Ya Shen, et al.
Journal of Ethnopharmacology (2025), pp. 119400-119400
Closed Access

Hepatoprotective Effects of Cilnidipine in Cholestatic Liver Disease: Role of FXR and NRF2 Signalling
Thamer Abdulla Mohammed, Munaf H. Zalzala
Journal of Experimental Pharmacology (2025) Vol. Volume 17, pp. 93-105
Open Access

MAPK13 phosphorylates PHGDH and promotes its degradation via chaperone-mediated autophagy during liver injury
Xing Ru, Ruilong Liu, Y. K. Stella Man, et al.
Cell Discovery (2025) Vol. 11, Iss. 1
Open Access

In Vitro-In Silico Models to Elucidate Mechanisms of Bile Acid Disposition and Cellular Aerobics in Human Hepatocytes
Kristof De Vos, Raf Mols, Sagnik Chatterjee, et al.
The AAPS Journal (2025) Vol. 27, Iss. 2
Closed Access

Animal models of biliary/cholestatic disease
Savneet Kaur, Dinesh Mani Tripathi
Elsevier eBooks (2025), pp. 185-214
Closed Access

Transcriptome and targeted metabolome analysis provide insights into bile acids' new roles and mechanisms on fat deposition and meat quality in lamb
Boyan Zhang, Zhiqiang Sun, Zhu Yu, et al.
Food Research International (2022) Vol. 162, pp. 111941-111941
Closed Access | Times Cited: 19

Loss of SLC27A5 Activates Hepatic Stellate Cells and Promotes Liver Fibrosis via Unconjugated Cholic Acid
Kang Wu, Yi Liu, Jie Xia, et al.
Advanced Science (2023) Vol. 11, Iss. 2
Open Access | Times Cited: 11

Activation of Nrf2/HO-1 signaling pathway exacerbates cholestatic liver injury
Yi Wang, Xiaolong Fu, Li Zeng, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 4

The gut microbiota-bile acid axis in cholestatic liver disease
Dayan Sun, Chuanping Xie, Yong Zhao, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 4

Bile Acids Activate NLRP3 Inflammasome, Promoting Murine Liver Inflammation or Fibrosis in a Cell Type-Specific Manner
Theresa Maria Holtmann, María Eugenia Inzaugarat, Jana Knorr, et al.
Cells (2021) Vol. 10, Iss. 10, pp. 2618-2618
Open Access | Times Cited: 26

Risk factors related to significant hepatic inflammation in patients with acute drug-induced liver injury
Yüting Xiong, Jianfei Wang, Le Li, et al.
iLiver (2024) Vol. 3, Iss. 2, pp. 100095-100095
Open Access | Times Cited: 3

Melatonin improves cholestatic liver disease via the gut‐liver axis
Xianjiao Liu, Jinyan Li, Mengdie Shi, et al.
Journal of Pineal Research (2023) Vol. 76, Iss. 1
Closed Access | Times Cited: 7

Page 1 - Next Page

Scroll to top